Member Info for Ctw2014

Bit of a mixed bag and, in some respects, raises more questions than answers. As Eshaitan points out, we are not showing enough revenue in the whole of the first half to account for the receipts you would expect for the 10,500 sq metres of tiles for the two orders mentioned alone. So, what do they mean by ‘completed’? It cannot mean fully delivered and paid for can it? So presumably they mean they have completed the cutting and polishing. Clarification would certainly be welcome. As ever with Fox, progress is slower than we would hope, but it is good progress nonetheless. I make the increase in revenues for the first half 85%. Revenue for the year to 31/12/17 was €1.2m. So if you apply that rate of increase to the whole year, we can expect a minimum revenue figure of €2.2m in my view. However, given everything that we know, that should be a wildly conservative estimate. So, for example, 6 months of the Chinese order of 300 tons a month at €170 per ton is €300,000 alone! As has already been suggested, an RNS on the Chinese order would probably have produced a decent rise in the sp on its own, but wrapping it up in the trading update has dulled its impact. This may not be the blockbuster RNS we were hoping for, but we are getting there and the recent rate of growth is actually quite impressive if viewed objectively and divorced from past delays. No doubt more detail to come and an update in September with the interims. Before that, we can hope for an interview with CG which might bring more clarification.

They said the end of the month and tomorrow is the end of the month.

We have beaten the one year average volume already today. Still plenty of interest in Prem. Looking backwards this looks pretty poor, but looking forwards it offers plenty of promise. GLA

..... to top up or buy before trading update!

... ready for news

He is not a new investor (see October RNS) but he has increased the number of shares held to get back close to the percentage he had before the last placing. Incidentally, my take is that, with respect, you guys may be over thinking where we are. We know that revenues will be massively up on the last update and I think the market will react positively to that because the direction of travel will be crystal clear. I don’t think it’s the be all and end all that we break even this year, although I would be surprised if we aren’t at least at break even currently (even if not over the year). Best wishes and GLA.

Call me a cynic but that’s pretty good timing for issuing those share options! No wonder the trading update was a bit bland🤔

Well not a lot of volume but, such as it is, not a bad reaction to today’s RNS.

I don’t often post on here, but for what its worth I am with Ant. Look at all the energy that other posters have expended responding to Earache’s speculation/interpretation. The fact is that with thinly traded AIM shares, a few buys or sells can affect the sp significantly and sentiment/doubt/fear/optimism/pessimism etc can drive those few buys/sells. The market makers simply respond to market supply and demand. Any sensible investor in a thinly traded AIm stock would be well advised to avoid fuelling doubt and fear about their own investment - common sense surely? And other investors would be happier too. Let’s focus on the positives for EMH and leave doubts and fears to the trolls and shorters. Goodness knows there are enough of those around, not that I am accusing anyone here of being in that camp.

And there it is. Had hoped for a bit more tbh but progress slowly being made. With import licences for the HCV kit being sought in 30 different countries we should see revenues grow in 2018/2019 onwards and with cash of £3.5m plus the bulk of the £2m in grants still to be recognised we are in a reasonably good state pending revenue growth coming through.

Last year we got one on the 13th July, so hopefully sometime soon.

1) I don’t mind if it’s suspended. Will stop selling and will probably have the suspension lifted after news. 2) Not worried about a placing. Loan RNS confirms there won’t be one until the loan is repaid. .18p is a good price after the Zulu news imo and brings my average down a bit. GLA

Hi interesting. Well, I bought back in just as the buys dried up and the sells reappeared! I jumped back out again a few days back. This is still being held down by a consistent round number seller.

Seller still around - Jeeze!

Well done Talygarntom although highlighting the rather cynical, negative and retrospective views from stockopedia in here on a share which has thin trading volumes can backfire in my view. We know there have been delays and a slower than anticipated build up of sales. However, we are past all that now imo and now looking at a rosey future.

Doesn’t really matter does it Draft. Free R&D. Getting into the NHS would be a pretty big deal.

I reckon this will bounce from here. Looks like most of those who were in for weed are now out. They have more cash to spend so news soon. Hopefully buy back.

Although one can’t always be certain, it looks to me that the bulk of today’s trades in value were buys although they are all shown as sells.

Lots of ‘pretty’s’ in that last post!

Very interesting to see the comparisons being drawn here with Mermeren. As has been highlighted, their results for 2017 highlight potential for very rapid revenue/profit growth here. Although they are obviously a competitor, as they only have one marble product (Sivec) I don’t see that as a major risk. Also they are listed on a pretty obscure exchange, their website is pretty basic compared to Fox’s now pretty slick one, and as has been pointed out, they are not in all our markets/potential markets. Overall, I am feeling pretty good about my investment in Fox. We just need more PIs to cotton on to the potential and......BOOM!